Voltage-gated sodium channels: new targets in cancer therapy?

Abstract : Early detection and treatment of cancers have increased survival and improved clinical outcome. The development of metastases is often associated with a poor prognostic of survival. Finding early markers of metastasis and developing new therapies against their development is a great challenge. Since a few years, there is more evidence that ionic channels are involved in the oncogenic process. Among these, voltage-gated sodium channels expressed in non-nervous or non-muscular organs are often associated with the metastatic behaviour of different cancers. The aim of this review is to describe the current knowledge on the functional expression of voltage-gated sodium channels and their biological roles in different cancers such as prostate, breast, lung (small cells and non-small cells) and leukaemia. In the conclusion, we develop conceptual approaches to understand how such channels can be involved in the metastatic process and conclude that blockers targeted toward these channels are promising new therapeutic solutions against metastatic cancers.
Type de document :
Article dans une revue
Current Pharmaceutical Design, Bentham Science Publishers, 2006, 12 (28), pp.3681-95
Liste complète des métadonnées

Littérature citée [32 références]  Voir  Masquer  Télécharger

Contributeur : Jean-Yves Le Guennec <>
Soumis le : vendredi 13 novembre 2009 - 11:07:48
Dernière modification le : lundi 2 juillet 2018 - 16:20:15
Document(s) archivé(s) le : mercredi 7 avril 2010 - 03:20:08


  • HAL Id : inserm-00141876, version 1
  • PUBMED : 17073667



Sébastien Roger, Marie Potier, Christophe Vandier, Pierre Besson, Jean-Yves Le Guennec. Voltage-gated sodium channels: new targets in cancer therapy?. Current Pharmaceutical Design, Bentham Science Publishers, 2006, 12 (28), pp.3681-95. 〈inserm-00141876〉



Consultations de la notice


Téléchargements de fichiers